Literature DB >> 18769450

Regulation of IL-2 expression by transcription factor BACH2 in umbilical cord blood CD4+ T cells.

M L Lesniewski1, P Haviernik, R P Weitzel, S Kadereit, M M Kozik, L R Fanning, Y C Yang, Y Hegerfeldt, M R Finney, M Z Ratajczak, N Greco, P Paul, J Maciejewski, M J Laughlin.   

Abstract

On activation, umbilical cord blood (UCB) CD4(+) T cells demonstrate reduced expression of tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), whereas maintaining equivalent interleukin-2 (IL-2) levels, as compared with adult peripheral blood (PB) CD4(+) T cells. Nuclear factor of activated T cells (NFAT1) protein, a transcription factor known to regulate the expression of IL-2, TNF-alpha and IFN-gamma, is reduced in resting and activated UCB CD4(+) T cells. In contrast, expression of Broad-complex-Tramtrack-Bric-a-Brac and Cap'n'collar homology 1 bZip transcription factor 2 (BACH2) was shown by gene array analyses to be increased in UCB CD4(+) T cells and was validated by qRT-PCR. Using chromatin immunoprecipitation, BACH2 was shown binding to the human IL-2 proximal promoter. Knockdown experiments of BACH2 by transient transfection of UCB CD4(+) T cells with BACH2 siRNA resulted in significant reductions in stimulated IL-2 production. Decreased IL-2 gene transcription in UCB CD4(+) T cells transfected with BACH2 siRNA was confirmed by a human IL-2 luciferase assay. In summary, BACH2 maintains IL-2 expression in UCB CD4(+) T cells at levels equivalent to adult PB CD4(+) T cells despite reduced NFAT1 protein expression. Thus, BACH2 expression is necessary to maintain IL-2 production when NFAT1 protein is reduced, potentially impacting UCB graft CD4(+) T-cell allogeneic responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769450     DOI: 10.1038/leu.2008.234

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  6 in total

1.  Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor.

Authors:  Yair Benita; Zhifang Cao; Cosmas Giallourakis; Chun Li; Agnès Gardet; Ramnik J Xavier
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

Review 2.  T Cell Fates Zipped Up: How the Bach2 Basic Leucine Zipper Transcriptional Repressor Directs T Cell Differentiation and Function.

Authors:  Martin J Richer; Mark L Lang; Noah S Butler
Journal:  J Immunol       Date:  2016-08-15       Impact factor: 5.422

3.  BACH2: a marker of DNA damage and ageing.

Authors:  L M Uittenboogaard; C Payan-Gomez; J Pothof; W van Ijcken; P G Mastroberardino; I van der Pluijm; J H J Hoeijmakers; M Tresini
Journal:  DNA Repair (Amst)       Date:  2013-09-24

4.  miR-182 and miR-10a are key regulators of Treg specialisation and stability during Schistosome and Leishmania-associated inflammation.

Authors:  Samir Kelada; Praveen Sethupathy; Isobel S Okoye; Eleni Kistasis; Stephanie Czieso; Sandra D White; David Chou; Craig Martens; Stacy M Ricklefs; Kimmo Virtaneva; Dan E Sturdevant; Stephen F Porcella; Yasmine Belkaid; Thomas A Wynn; Mark S Wilson
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

5.  Bach2 represses the AP-1-driven induction of interleukin-2 gene transcription in CD4+ T cells.

Authors:  Eunkyeong Jang; Hye Rim Lee; Geon Hee Lee; Ah-Reum Oh; Ji-Young Cha; Kazuhiko Igarashi; Jeehee Youn
Journal:  BMB Rep       Date:  2017-09       Impact factor: 4.778

6.  The Role of BACH2 in T Cells in Experimental Malaria Caused by Plasmodium chabaudi chabaudi AS.

Authors:  Chelsea L Edwards; Marcela Montes de Oca; Fabian de Labastida Rivera; Rajiv Kumar; Susanna S Ng; Yulin Wang; Fiona H Amante; Kohei Kometani; Tomohiro Kurosaki; Tom Sidwell; Axel Kallies; Christian R Engwerda
Journal:  Front Immunol       Date:  2018-11-06       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.